Acute esophageal necrosis (black esophagus) in the renal transplant recipient: Manifestation of primary cytomegalovirus infection

Transplant Infectious Disease

Volumn 9, Issue 1, 2007, Pages 42-45

  Trappe, R ^a   Pohl, H ^a   Forberger, A ^a   Schindler, R ^a   Reinke, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute esophageal necrosis; Black esophagus; CMV infection; Renal transplantation

Indexed keywords

GANCICLOVIR; LIVER ENZYME; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTON PUMP INHIBITOR; SUCRALFATE; TACROLIMUS;

ABDOMINAL PAIN; ACUTE ESOPHAGUS NECROSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; EPIGASTRIC PAIN; ESOPHAGUS DISEASE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ABDOMINAL PAIN; ACUTE DISEASE; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; ESOPHAGITIS; ESOPHAGUS; GANCICLOVIR; HUMANS; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MIDDLE AGED; NECROSIS; POSTOPERATIVE COMPLICATIONS; STOMACH; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33846976516     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00158.x     Document Type: Article

References (25)

1. Katsinelos P, Pilpilidis I, Dimiropoulos S, et al. Black esophagus induced by severe vomiting in a healthy young man. Surg Endosc 2003; 17: 521.
2. Jacobsen NO, Christiansen J, Kruse A. Incidence of oesophageal necrosis in an autopsy material. Apmis 2003; 111: 591-594.
3. Goldenberg SP, Wain SL, Marignani P. Acute necrotizing esophagitis. Gastroenterology 1990; 98: 493-496.
4. Haviv YS, Reinus C, Zimmerman J. "Black esophagus": a rare complication of shock. Am J Gastroenterol 1996; 9: 2432-2434.
5. Mangan TF, Colley AT, Wytock DH. Antibiotic-associated acute necrotizing esophagitis. Gastroenterology 1990; 99: 900.
6. Lacy BE, Toor A, Bensen SP, et al. Acute esophageal necrosis: report of two cases and a review of the literature. Gastrointest Endosc 1999; 49 (4 Part 1): 527-532.
7. Ben Soussan E, Savoye G, Hochain P, et al. Acute esophageal necrosis: a 1-year prospective study. Gastrointest Endosc 2002; 56: 213-217.
8. Cattan P, Cuillerier E, Cellier C, et al. Black esophagus associated with herpes esophagitis. Gastrointest Endosc 1999; 49: 105-107.
9. Kram M, Gorenstein L, Eisen D, Cohen D. Acute esophageal necrosis associated with gastric volvulus. Gastrointest Endosc 2000; 51: 610-612.
10. Mahe A, Keita S, Blanc L, Bobin P. Esophageal necrosis in the Stevens-Johnson syndrome. J Am Acad Dermatol 1993; 29: 103-104.
11. Cohen J, Corey G. Cytomegalovirus infection in the normal host. Medicine (Baltimore) 1985; 64: 100-114.
12. Horwitz C, Henle W, Henle G, et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously health individuals. Report of 82 cases. Medicine (Baltimore) 1986; 65: 124-134.
13. Preiksaitis J, Brennan D, Fishman J, Allen U. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5: 218-227.
14. American Society of Transplantation Infectious Disease Community of Practice. Cytomegalovirus. Am J Transplant 2004; 4: 51-54.
15. Vodovnik A, Cerar A. Synchronous herpes simplex virus and cytomegalovirus esophagitis. Z Gastroenterol 2000; 38: 491-494.
16. Schmidt CA, Oettle H, Peng R, et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation 1995; 59: 1133-1138.
17. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002; 13: 277-287.
18. Buckner FS, Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993; 17: 644-656.
19. Shrestha BM, Parton D, Gray A, et al. Cytomegalovirus involving gastrointestinal tract in renal transplant recipients. Clin Transplant 1996; 10: 170-175.
20. Akalin E, Sehgal V, Ames S, et al. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 2003; 3: 731-735.
21. Paya C, HumarA, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611-620.
22. Taber DJ, Ashcraft E, Baillie GM, et al. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis 2004; 6: 101-109.
23. Ozaki KS, Pestana JO, Granato CF, et al. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies. Transpl Infect Dis 2004; 6: 63-68.
24. Seehofer D, Meisel H, Rayes N, et al. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplant 2004; 4: 1331-1337.
25. Fellay J, Venetz J, Pascual M, et al. Treatment of cytomegalovirous infection or disease in solid organ transplant recipients with valganciclovir. Am J Transplant 2005; 5: 1781-1782.